Truist Financial’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Truist Financial’s Portfolio IEIH Stock Details IEIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-55,554	Closed	-$1.83M	–	2723
2022 Q2	$1.83M	Buy	+55,554	New	+$1.82M	﹤0.01%	1264
2022 Q1	–	Sell	-101,620	Closed	-$3.6M	–	2906
2021 Q4	$3.6M	Buy	101,620 +2,481	+3%	+$86.6K	0.01%	1018
2021 Q3	$3.48M	Sell	99,139 -12	-0%	-$435	0.01%	1024
2021 Q2	$3.47M	Buy	99,151 +1,256	+1%	+$41.9K	0.01%	1030
2021 Q1	$3.17M	Buy	97,895 +47,850	+96%	+$1.59M	0.01%	1024
2020 Q4	$1.62M	Buy	+50,045	New	+$1.56M	﹤0.01%	1267

Truist Financial's IEIH Position: Q3 2022 in Review

Truist Financial sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 55,554 shares — an estimated $1.83M sold.

Truist Financial first reported a position in IEIH in Q4 2020 and held it in 6 quarters. The position peaked at $3.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

Truist Financial reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
Truist Financial sold 55,554 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $1.83M.
Truist Financial first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q4 2020 and held it in 6 quarters.
Truist Financial's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $3.6M in Q4 2021.
0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Truist Financial's 13F filing for Q3 2022, filed 26 Oct 2022.